Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse.

Yusta B, Matthews D, Koehler JA, Pujadas G, Kaur KD, Drucker DJ.

Endocrinology. 2019 Aug 1;160(8):1950-1963. doi: 10.1210/en.2019-00398.

PMID:
31237617
2.

GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr-/- mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomy.

Patel A, Yusta B, Matthews D, Charron MJ, Seeley RJ, Drucker DJ.

Mol Metab. 2018 Oct;16:45-54. doi: 10.1016/j.molmet.2018.06.006. Epub 2018 Jun 9.

3.

GLP-1 Receptor Expression Within the Human Heart.

Baggio LL, Yusta B, Mulvihill EE, Cao X, Streutker CJ, Butany J, Cappola TP, Margulies KB, Drucker DJ.

Endocrinology. 2018 Apr 1;159(4):1570-1584. doi: 10.1210/en.2018-00004.

4.

Inactivation of the Glucose-Dependent Insulinotropic Polypeptide Receptor Improves Outcomes following Experimental Myocardial Infarction.

Ussher JR, Campbell JE, Mulvihill EE, Baggio LL, Bates HE, McLean BA, Gopal K, Capozzi M, Yusta B, Cao X, Ali S, Kim M, Kabir MG, Seino Y, Suzuki J, Drucker DJ.

Cell Metab. 2018 Feb 6;27(2):450-460.e6. doi: 10.1016/j.cmet.2017.11.003. Epub 2017 Dec 21.

5.

Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway.

Yusta B, Matthews D, Flock GB, Ussher JR, Lavoie B, Mawe GM, Drucker DJ.

Mol Metab. 2017 Mar 31;6(6):503-511. doi: 10.1016/j.molmet.2017.03.006. eCollection 2017 Jun.

6.

Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport.

Lee J, Koehler J, Yusta B, Bahrami J, Matthews D, Rafii M, Pencharz PB, Drucker DJ.

Mol Metab. 2017 Jan 17;6(3):245-255. doi: 10.1016/j.molmet.2017.01.005. eCollection 2017 Mar.

7.

Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.

Mulvihill EE, Varin EM, Gladanac B, Campbell JE, Ussher JR, Baggio LL, Yusta B, Ayala J, Burmeister MA, Matthews D, Bang KWA, Ayala JE, Drucker DJ.

Cell Metab. 2017 Jan 10;25(1):152-165. doi: 10.1016/j.cmet.2016.10.007. Epub 2016 Nov 10.

8.

GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7.

Koehler JA, Baggio LL, Yusta B, Longuet C, Rowland KJ, Cao X, Holland D, Brubaker PL, Drucker DJ.

Cell Metab. 2015 Mar 3;21(3):379-91. doi: 10.1016/j.cmet.2015.02.005.

9.

GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R.

Yusta B, Baggio LL, Koehler J, Holland D, Cao X, Pinnell LJ, Johnson-Henry KC, Yeung W, Surette MG, Bang KW, Sherman PM, Drucker DJ.

Diabetes. 2015 Jul;64(7):2537-49. doi: 10.2337/db14-1577. Epub 2015 Mar 3.

10.

Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2.

Drucker DJ, Yusta B.

Annu Rev Physiol. 2014;76:561-83. doi: 10.1146/annurev-physiol-021113-170317. Epub 2013 Oct 25. Review.

PMID:
24161075
11.

GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice.

Panjwani N, Mulvihill EE, Longuet C, Yusta B, Campbell JE, Brown TJ, Streutker C, Holland D, Cao X, Baggio LL, Drucker DJ.

Endocrinology. 2013 Jan;154(1):127-39. doi: 10.1210/en.2012-1937. Epub 2012 Nov 26.

PMID:
23183176
12.
13.

Disruption of the murine Glp2r impairs Paneth cell function and increases susceptibility to small bowel enteritis.

Lee SJ, Lee J, Li KK, Holland D, Maughan H, Guttman DS, Yusta B, Drucker DJ.

Endocrinology. 2012 Mar;153(3):1141-51. doi: 10.1210/en.2011-1954. Epub 2012 Jan 17.

14.

ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowel.

Bahrami J, Yusta B, Drucker DJ.

Gastroenterology. 2010 Jun;138(7):2447-56. doi: 10.1053/j.gastro.2010.03.006. Epub 2010 Mar 10.

PMID:
20226187
15.

ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut.

Yusta B, Holland D, Koehler JA, Maziarz M, Estall JL, Higgins R, Drucker DJ.

Gastroenterology. 2009 Sep;137(3):986-96. doi: 10.1053/j.gastro.2009.05.057. Epub 2009 Jun 9.

PMID:
19523469
16.

Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.

Koehler JA, Harper W, Barnard M, Yusta B, Drucker DJ.

Cancer Res. 2008 Oct 1;68(19):7897-904. doi: 10.1158/0008-5472.CAN-08-0029.

17.

Glucagon receptor signaling is essential for control of murine hepatocyte survival.

Sinclair EM, Yusta B, Streutker C, Baggio LL, Koehler J, Charron MJ, Drucker DJ.

Gastroenterology. 2008 Dec;135(6):2096-106. doi: 10.1053/j.gastro.2008.07.075. Epub 2008 Aug 3.

PMID:
18809404
18.

GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress.

Yusta B, Baggio LL, Estall JL, Koehler JA, Holland DP, Li H, Pipeleers D, Ling Z, Drucker DJ.

Cell Metab. 2006 Nov;4(5):391-406.

20.
21.

[GLP-2 peptide(glucagon-like peptide-2) controls energetic homeostasis by actions on proliferation and cytoprotection in the gastrointestinal epithelium].

Yusta B, Drucker DJ.

Journ Annu Diabetol Hotel Dieu. 2004:127-37. Review. French. No abstract available.

PMID:
15259311
22.

Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization.

Estall JL, Yusta B, Drucker DJ.

Mol Biol Cell. 2004 Aug;15(8):3673-87. Epub 2004 May 28.

23.

IGF-I signaling prevents dehydroepiandrosterone (DHEA)-induced apoptosis in hypothalamic neurons.

Lin SY, Cui H, Yusta B, Belsham DD.

Mol Cell Endocrinol. 2004 Feb 12;214(1-2):127-35.

PMID:
15062551
24.

Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa.

Walsh NA, Yusta B, DaCambra MP, Anini Y, Drucker DJ, Brubaker PL.

Endocrinology. 2003 Oct;144(10):4385-92. Epub 2003 Jul 3.

PMID:
12960094
25.

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.

Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ.

J Biol Chem. 2003 Jan 3;278(1):471-8. Epub 2002 Oct 29.

27.

Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling.

Lovshin J, Estall J, Yusta B, Brown TJ, Drucker DJ.

J Biol Chem. 2001 Jun 15;276(24):21489-99. Epub 2001 Mar 21.

29.

New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2.

Drucker DJ, Lovshin J, Baggio L, Nian M, Adatia F, Boushey RP, Liu Y, Saleh J, Yusta B, Scrocchi L.

Ann N Y Acad Sci. 2000;921:226-32. Review.

PMID:
11193827
30.

Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine.

Lovshin J, Yusta B, Iliopoulos I, Migirdicyan A, Dableh L, Brubaker PL, Drucker DJ.

Endocrinology. 2000 Nov;141(11):4194-201.

PMID:
11089553
31.

Enteroendocrine localization of GLP-2 receptor expression in humans and rodents.

Yusta B, Huang L, Munroe D, Wolff G, Fantaske R, Sharma S, Demchyshyn L, Asa SL, Drucker DJ.

Gastroenterology. 2000 Sep;119(3):744-55.

PMID:
10982769
33.

Structural determinants for activity of glucagon-like peptide-2.

DaCambra MP, Yusta B, Sumner-Smith M, Crivici A, Drucker DJ, Brubaker PL.

Biochemistry. 2000 Aug 1;39(30):8888-94.

PMID:
10913301
34.

Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis.

Boushey RP, Yusta B, Drucker DJ.

Am J Physiol. 1999 Nov;277(5):E937-47. doi: 10.1152/ajpendo.1999.277.5.E937.

PMID:
10567023
35.

Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.

Yusta B, Somwar R, Wang F, Munroe D, Grinstein S, Klip A, Drucker DJ.

J Biol Chem. 1999 Oct 22;274(43):30459-67.

36.

Biologic properties and therapeutic potential of glucagon-like peptide-2.

Drucker DJ, Boushey RP, Wang F, Hill ME, Brubaker PL, Yusta B.

JPEN J Parenter Enteral Nutr. 1999 Sep-Oct;23(5 Suppl):S98-100. Review.

PMID:
10483906
37.

Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis.

Drucker DJ, Yusta B, Boushey RP, DeForest L, Brubaker PL.

Am J Physiol. 1999 Jan;276(1):G79-91. doi: 10.1152/ajpgi.1999.276.1.G79.

PMID:
9886982
38.

The thyrotropin beta-subunit gene is repressed by thyroid hormone in a novel thyrotrope cell line, mouse T alphaT1 cells.

Yusta B, Alarid ET, Gordon DF, Ridgway EC, Mellon PL.

Endocrinology. 1998 Nov;139(11):4476-82.

PMID:
9794455
40.

Structural characterization by affinity cross-linking of glucagon-like peptide-1(7-36)amide receptor in rat brain.

Calvo JC, Yusta B, Mora F, Blázquez E.

J Neurochem. 1995 Jan;64(1):299-306.

PMID:
7798926
41.

Expression of insulin-like growth factor-I (IGF-I) receptor gene in rat brain and liver during development and in regenerating adult rat liver.

Santos A, Yusta B, Fernández-Moreno MD, Blázquez E.

Mol Cell Endocrinol. 1994 May;101(1-2):85-93.

PMID:
9397940
42.

Regulation of thyroid hormone receptor and c-erbA mRNA levels by butyrate in neuroblastoma (N2A) and glioma (C6) cells.

Yusta B, Ortiz-Caro J, Bedo G, Pascual A, Aranda A.

J Neurosci Res. 1990 Sep;27(1):1-9.

PMID:
1979350
44.

Sodium butyrate induces major morphological changes in C6 glioma cells that are correlated with increased synthesis of a spectrin-like protein.

Hargreaves AJ, Yusta B, Avila J, Hesketh JE, Aranda A, Pascual A.

Brain Res Dev Brain Res. 1989 Feb 1;45(2):291-5.

PMID:
2653664
46.

Proliferation and differentiation are not directly related to H1(0) accumulation in cultured glial cells.

Ortiz-Caro J, Yusta B, Pascual A, Aranda A.

Brain Res. 1988 Aug 1;470(2):229-37.

PMID:
3219583
47.

Mechanism of L-triiodothyronine (T3) uptake by glial C6 cells: regulation by butyrate.

Yusta B, Ortiz-Caro J, Pascual A, Aranda A.

Mol Cell Endocrinol. 1988 Aug;58(2-3):191-8.

PMID:
3208994
48.

Short chain fatty acids modulate nuclear receptor and extranuclear L-triiodothyronine levels in glial C6 cells by different mechanisms.

Ortiz-Caro J, Montiel F, Yusta B, Pascual A, Aranda A.

Endocrinology. 1988 Jun;122(6):2597-603.

PMID:
2836168
49.

Evidence for the presence of nuclear 3,5,3'-triiodothyronine receptors in secondary cultures of pure rat oligodendrocytes.

Yusta B, Besnard F, Ortiz-Caro J, Pascual A, Aranda A, Sarliève L.

Endocrinology. 1988 May;122(5):2278-84.

PMID:
3359982
50.

Supplemental Content

Support Center